LAS VEGAS, NV / ACCESSWIRE / October 3, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced today that the Company's Board of Directors appointed Mr. William "Trip" Thomas as its Chief Financial Officer effective October 1, 2024.
LAS VEGAS, NV / ACCESSWIRE / August 20, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products and services, announced today that the Company is voluntarily delisting its common stock ("Common Stock") from trading on the OTCQB Venture Market. Delisting from the OTCQB Venture Market will have no impact on Company's Common Shares which will continue to trade on the OTC Pink Open Market providing stockholders the ability to trade their shares in the public market as they can do now.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Charles K. Martin CEO | OTC PINK Exchange | 12506E103 CUSIP |
| US Country | 4 Employees | - Last Dividend | 25 Jun 1998 Last Split | - IPO Date |
CB Scientific, Inc. operates within the healthcare sector, focusing specifically on the ambulatory non-invasive cardiac monitoring space both domestically in the United States and across the globe. The company's offerings are designed to cater to patients at risk of abnormal heart rhythms by ensuring improved compliance through innovative solutions. Based in Las Vegas, Nevada, CB Scientific, Inc. is committed to providing accurate and essential cardiac health information to physicians, thereby supporting enhanced patient care and treatment outcomes.
CB Scientific, Inc. provides state-of-the-art EKG devices that are integral to monitoring cardiac health, especially for patients with a heightened risk of developing abnormal heart rhythms. These devices are designed for ambulatory use, offering patients the flexibility to continue with their daily activities while under continuous monitoring.
The company’s cloud-based software enables the seamless acquisition and storage of cardiac data. This platform allows for the real-time analysis and management of EKG readings, which can be crucial for timely decision-making and treatment adjustments by healthcare professionals.
Complementing its hardware offerings, CB Scientific, Inc. also provides smartphone apps that enhance patient compliance and engagement. These apps facilitate easy interaction with the EKG devices and the cloud platform, ensuring that patients are actively involved in monitoring their cardiac health and can share vital health data effortlessly with their physicians.